ER
Eyestem Research
India · Biotech
Bengaluru biotechnology company developing scalable cell replacement therapies.
Product
Eyestem Research develops cell replacement therapies intended to treat diseases with limited treatment options. The Bengaluru company combines cell biology, clinical development and manufacturing processes to produce therapies that can be supplied at scale.
Its lead programme, Eyecyte-RPE, targets geographic atrophy associated with dry age-related macular degeneration. Eyestem is evaluating the investigational therapy in clinical trials and is also developing a broader regenerative medicine pipeline.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| RDI cell therapy loan | ₹1.3B | Technology Development Board — Participant |